Metastatic colorectal cancer patients could find hope in new FDA-approved treatment

The U.S. Food and Drug Administration on Nov. 8 approved a new oral medicine called Fruzaqla (fruquintinib) for the treatment of patients with previously treated metastatic colorectal cancer.

Related Keywords

United States ,Massachusetts ,Pennsylvania ,Tennessee ,Cambridge ,Cambridgeshire ,United Kingdom ,Vanderbilt University ,American ,Maged Khalil ,Cathy Eng ,Melissa Rudy ,Teresa Bitetti ,Journal Of The American Medical Association ,Drug Administration ,Vanderbilt University Medical Center ,Takeda Pharmaceuticals Inc ,American Cancer Society ,Global Oncology Business Unit ,Fox News ,American Medical ,Lehigh Valley Topper Cancer Institute ,Leigh Valley Health Network ,Takeda Pharmaceuticals ,